The efficacy and safety of cannabidiol (CBD) in pediatric patients with Dravet Syndrome: a narrative review of clinical trials

Nicholas Aderinto,Gbolahan Olatunji,Emmanuel Kokori,Yusuf Ismaila Ajayi,Olumide Akinmoju,Abiola Samuel Ayedun,Oluwapelumi Ikeoluwa Ayoola,Noah Oluwaseun Aderinto
DOI: https://doi.org/10.1186/s40001-024-01788-6
IF: 4.981
2024-03-19
European Journal of Medical Research
Abstract:Dravet Syndrome (DS) is a rare and severe form of childhood epilepsy that is often refractory to conventional antiepileptic drugs. Emerging evidence suggests that Cannabidiol (CBD) offer therapeutic benefits for DS. This review aims to evaluate the efficacy and safety of CBD in pediatric patients with DS based on data from ten clinical trials.
medicine, research & experimental
What problem does this paper attempt to address?